Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)

Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)

Methods A randomized, double-blind, placebo-controlled, single-center, cross-over study including 63 patients allergic to ragweed pollen was conducted.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S55-S55
Hauptverfasser: Salapatek, A, McCue, S, Patel, D, Patel, P, Pipkin, J.D, Zimmerer, R.O
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Pollen
Quality of life
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S55
container_issue 2
container_start_page S55
container_title Journal of allergy and clinical immunology
container_volume 121
creator Salapatek, A
McCue, S
Patel, D
Patel, P
Pipkin, J.D
Zimmerer, R.O
description Methods A randomized, double-blind, placebo-controlled, single-center, cross-over study including 63 patients allergic to ragweed pollen was conducted.
doi_str_mv 10.1016/j.jaci.2007.12.222
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1504898605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674907026504</els_id><sourcerecordid>3240026931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2232-80c9048ec27301ff19f51cd8ac040047080e91ab4f8a07c44b399346b7aa1b5e3</originalsourceid><addsrcrecordid>eNp9Us1u0zAcDwgkyuAB4GSJS3tIZjtpPiQ0aUQZIFVsbbez5Tj_tA6pHeykpS-1J-DEA_BMOCsCaQdOlv3_fdn-ed5bggOCSXzeBA0XMqAYJwGhAaX0qTchOEv8OKXzZ94E44z4cRJlL7yX1jbY7cM0mzx5sxx4K_sj0jVayBrQdHm9mCGp0IpvDgAVumxbMBsp0A3vJajeolsDvHeTg-y3KOddL61u_ULxsnWnP-_Rh6ECq5WsAH3hlrdorduhl1qhaUh__dic287w4wwdtqBQ8b3T1vF6_dfyRjtPNYbgbq720mi1c9ZO6QE9GED5lu9KMGhaFPkM3VmpNg_oIvfXHQhZu8SrrVRaaNUMSvRyL11Q9Pi-ywHsGE1x6VRHNX_lnmA5e-U9r3lr4fWf9cy7uypu80_-4vrj5_xy4QtKQ-qnWGQ4SkHQJMSkrklWz4moUi5whHGU4BRDRngZ1SnHiYiiMsyyMIrLhHNSziE8896ddDujv41hWKMHo5wlI3OnnKUxnjsUPaGE0dYaqFln5I6bIyOYjRVgDRsrwMYKMEKZq4AjvT-RwOXfSzDMCveFAip3V9GzSsv_0y8e0UUrlRS8_QpHsP9iMksZZuuxY2PFcIJp7KKHvwGNwtE1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504898605</pqid></control><display><type>article</type><title>Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)</title><source>ScienceDirect</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Salapatek, A ; McCue, S ; Patel, D ; Patel, P ; Pipkin, J.D ; Zimmerer, R.O</creator><creatorcontrib>Salapatek, A ; McCue, S ; Patel, D ; Patel, P ; Pipkin, J.D ; Zimmerer, R.O</creatorcontrib><description>Methods A randomized, double-blind, placebo-controlled, single-center, cross-over study including 63 patients allergic to ragweed pollen was conducted.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2007.12.222</identifier><language>eng</language><publisher>St. Louis: Mosby, Inc</publisher><subject>Allergy and Immunology ; Pollen ; Quality of life</subject><ispartof>Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S55-S55</ispartof><rights>American Academy of Allergy, Asthma &amp; Immunology</rights><rights>2008 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright Elsevier Limited Feb 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2007.12.222$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Salapatek, A</creatorcontrib><creatorcontrib>McCue, S</creatorcontrib><creatorcontrib>Patel, D</creatorcontrib><creatorcontrib>Patel, P</creatorcontrib><creatorcontrib>Pipkin, J.D</creatorcontrib><creatorcontrib>Zimmerer, R.O</creatorcontrib><title>Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)</title><title>Journal of allergy and clinical immunology</title><description>Methods A randomized, double-blind, placebo-controlled, single-center, cross-over study including 63 patients allergic to ragweed pollen was conducted.</description><subject>Allergy and Immunology</subject><subject>Pollen</subject><subject>Quality of life</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9Us1u0zAcDwgkyuAB4GSJS3tIZjtpPiQ0aUQZIFVsbbez5Tj_tA6pHeykpS-1J-DEA_BMOCsCaQdOlv3_fdn-ed5bggOCSXzeBA0XMqAYJwGhAaX0qTchOEv8OKXzZ94E44z4cRJlL7yX1jbY7cM0mzx5sxx4K_sj0jVayBrQdHm9mCGp0IpvDgAVumxbMBsp0A3vJajeolsDvHeTg-y3KOddL61u_ULxsnWnP-_Rh6ECq5WsAH3hlrdorduhl1qhaUh__dic287w4wwdtqBQ8b3T1vF6_dfyRjtPNYbgbq720mi1c9ZO6QE9GED5lu9KMGhaFPkM3VmpNg_oIvfXHQhZu8SrrVRaaNUMSvRyL11Q9Pi-ywHsGE1x6VRHNX_lnmA5e-U9r3lr4fWf9cy7uypu80_-4vrj5_xy4QtKQ-qnWGQ4SkHQJMSkrklWz4moUi5whHGU4BRDRngZ1SnHiYiiMsyyMIrLhHNSziE8896ddDujv41hWKMHo5wlI3OnnKUxnjsUPaGE0dYaqFln5I6bIyOYjRVgDRsrwMYKMEKZq4AjvT-RwOXfSzDMCveFAip3V9GzSsv_0y8e0UUrlRS8_QpHsP9iMksZZuuxY2PFcIJp7KKHvwGNwtE1</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Salapatek, A</creator><creator>McCue, S</creator><creator>Patel, D</creator><creator>Patel, P</creator><creator>Pipkin, J.D</creator><creator>Zimmerer, R.O</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20080201</creationdate><title>Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)</title><author>Salapatek, A ; McCue, S ; Patel, D ; Patel, P ; Pipkin, J.D ; Zimmerer, R.O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2232-80c9048ec27301ff19f51cd8ac040047080e91ab4f8a07c44b399346b7aa1b5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Allergy and Immunology</topic><topic>Pollen</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salapatek, A</creatorcontrib><creatorcontrib>McCue, S</creatorcontrib><creatorcontrib>Patel, D</creatorcontrib><creatorcontrib>Patel, P</creatorcontrib><creatorcontrib>Pipkin, J.D</creatorcontrib><creatorcontrib>Zimmerer, R.O</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salapatek, A</au><au>McCue, S</au><au>Patel, D</au><au>Patel, P</au><au>Pipkin, J.D</au><au>Zimmerer, R.O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2008-02-01</date><risdate>2008</risdate><volume>121</volume><issue>2</issue><spage>S55</spage><epage>S55</epage><pages>S55-S55</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Methods A randomized, double-blind, placebo-controlled, single-center, cross-over study including 63 patients allergic to ragweed pollen was conducted.</abstract><cop>St. Louis</cop><pub>Mosby, Inc</pub><doi>10.1016/j.jaci.2007.12.222</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S55-S55
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_1504898605
source ScienceDirect; Free E-Journal (出版社公開部分のみ）
subjects Allergy and Immunology
Pollen
Quality of life
title Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A52%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quality%20of%20Life%20(QOL)%20in%20Ragweed%20Allergic%20Patients%20Treated%20with%20Captisol-Enabled%20%C2%AE%20Budesonide%20Nasal%20Solution%20(32%CE%BCg/spray)%20when%20Exposed%20to%20Ragweed%20Pollen%20in%20an%20Environmental%20Exposure%20Chamber%20(EEC)%20Using%20an%20EEC-Specific%20Rhinoconjunctivitis%20Quality%20of%20Life%20Questionnaire%20(EEC-RQOLQ)&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Salapatek,%20A&rft.date=2008-02-01&rft.volume=121&rft.issue=2&rft.spage=S55&rft.epage=S55&rft.pages=S55-S55&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2007.12.222&rft_dat=%3Cproquest_cross%3E3240026931%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504898605&rft_id=info:pmid/&rft_els_id=1_s2_0_S0091674907026504&rfr_iscdi=true